SEC 13F Intelligence

Managers / Q1 2023 · view latest →

Valliance Asset Management Ltd

CIK 0001846639 · 16/F, 8 QUEEN'S ROAD, CENTRAL, K3, 000000 · 852 35657001

Reported Value
$56M
Q1 2023
Positions
9
Filings on Record
22
2019–present window
Filed
May 10, 2023
original filing

Summary

Valliance Asset Management Ltd reported $56M in U.S.-listed holdings across 9 positions for Q1 2023.

The portfolio is heavily concentrated: BABA alone accounts for 54.4% of reported value.

Compared with Q4 2022, the fund opened 6 new positions and exited 5.

Portfolio Metrics

Turnover
+39.8%
vs prior filed quarter
Largest Position
+54.4%
Alibaba Group Hldg
New / Exited
6 / 5
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’20: $47MQ4 ’20Q1 ’21: $8MQ2 ’21: $23MQ3 ’21: $99MQ3 ’21Q4 ’21: $41MQ1 ’22: $18MQ2 ’22: $24MQ2 ’22Q3 ’22: $36MQ4 ’22: $71MQ1 ’23: $56MQ1 ’23Q2 ’23: $6MQ3 ’23: $27MQ4 ’23: $3MQ4 ’23Q1 ’24: $41MQ2 ’24: $66MQ3 ’24: $82MQ3 ’24Q4 ’24: $56MQ1 ’25: $44MQ2 ’25: $13MQ2 ’25Q3 ’25: $13MQ4 ’25: $240MQ1 ’26: $122MQ1 ’26filingsflow.com

Portfolio Composition

By security type
ADR: 95.1%Other: 4.9%
  • ADR · 95.1% · $53M
  • Other · 4.9% · $3M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
BILIBILIBILI INCNEW+453.6K453.6K+$11M$11M
FUTUFUTU HLDGS LTDNEW+91.0K91.0K+$5M$5M
YS BIOPHARMA CO LTDNEW+1.61M1.61M+$3M$3M
HTHTH WORLD GROUP LTDNEW+45.9K45.9K+$2M$2M
YS BIOPHARMA CO LTDNEW+750.0K750.0K+$116,775$116,775
HH&L ACQUISITION CONEW+400.0K400.0K+$28,000$28,000
JDJD.COM INCSOLD OUT186.2K0$10M$0
SUMMIT HEALTHCRE ACQUISTN COSOLD OUT1.00M0$10M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2023

8 positions
#IssuerClass% PortfolioValueShares
1BABAALIBABA GROUP HLDG LTDhistory →SPONSORED ADS54.39%$30M298.1K
2BILIBILIBILI INChistory →SPONS ADS REP Z19.04%$11M453.6K
3FUTUFUTU HLDGS LTDhistory →SPON ADS CL A8.43%$5M91.0K
4TSMTAIWAN SEMICONDUCTOR MFG LTDhistory →SPONSORED ADS6.58%$4M39.6K
5YS BIOPHARMA CO LTDORDINARY SHARES · *W EXP 03/15/2024.80%$3M2.36M
6HTHTH WORLD GROUP LTDhistory →SPONSORED ADS4.01%$2M45.9K
7GOTUGAOTU TECHEDU INChistory →SPONSORED ADS2.70%$2M357.8K
8HH&L ACQUISITION CO*W EXP 02/04/2020.05%$28,000400.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$122M8May 12, 202613F-HRchanges · EDGAR ↗
Q4 2025$240M11Feb 13, 202613F-HRchanges · EDGAR ↗
Q3 2025$13M1Oct 22, 202513F-HRchanges · EDGAR ↗
Q2 2025$13M5Jul 31, 202513F-HRchanges · EDGAR ↗
Q1 2025$44M25May 8, 202513F-HRchanges · EDGAR ↗
Q4 2024$56M18Feb 4, 202513F-HRchanges · EDGAR ↗
Q3 2024$82M7Oct 31, 202413F-HRchanges · EDGAR ↗
Q2 2024$66M15Aug 7, 202413F-HRchanges · EDGAR ↗
Q1 2024$41M8May 7, 202413F-HRchanges · EDGAR ↗
Q4 2023$3M6Jan 31, 202413F-HRchanges · EDGAR ↗
Q3 2023$27M14Oct 27, 202313F-HRchanges · EDGAR ↗
Q2 2023$6M4Jul 26, 202313F-HRchanges · EDGAR ↗
Q1 2023$56M9May 10, 202313F-HRchanges · EDGAR ↗
Q4 2022$71M8Feb 7, 202313F-HRchanges · EDGAR ↗
Q3 2022$36M6Nov 9, 202213F-HRchanges · EDGAR ↗
Q2 2022$24M3Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$18M2Apr 25, 202213F-HRchanges · EDGAR ↗
Q4 2021$41M3Jan 28, 202213F-HRchanges · EDGAR ↗
Q3 2021$99M6Oct 27, 202113F-HRchanges · EDGAR ↗
Q2 2021$23M3Jul 28, 202113F-HRchanges · EDGAR ↗
Q1 2021$8M1May 5, 202113F-HRchanges · EDGAR ↗
Q4 2020$47M3Feb 18, 202113F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.